nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—ADRB2—dilated cardiomyopathy	0.895	1	CbGaD
Dipivefrin—Bambuterol—ADRB2—dilated cardiomyopathy	0.00495	0.489	CrCbGaD
Dipivefrin—Epinephrine—SLC22A5—dilated cardiomyopathy	0.00177	0.175	CrCbGaD
Dipivefrin—Epinephrine—ADRB1—dilated cardiomyopathy	0.00122	0.121	CrCbGaD
Dipivefrin—Epinephrine—TNF—dilated cardiomyopathy	0.00116	0.114	CrCbGaD
Dipivefrin—Epinephrine—ADRB2—dilated cardiomyopathy	0.00103	0.101	CrCbGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000133	0.0014	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000132	0.0014	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ANKRD1—dilated cardiomyopathy	0.000131	0.00138	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000131	0.00138	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00013	0.00137	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00013	0.00137	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00013	0.00137	CbGpPWpGaD
Dipivefrin—ADRA2B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00013	0.00137	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000129	0.00136	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—SDHA—dilated cardiomyopathy	0.000128	0.00135	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000128	0.00135	CbGpPWpGaD
Dipivefrin—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000127	0.00134	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000126	0.00133	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—TAZ—dilated cardiomyopathy	0.000123	0.0013	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000123	0.0013	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000123	0.0013	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000122	0.00129	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000122	0.00128	CbGpPWpGaD
Dipivefrin—ADRA2C—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000121	0.00128	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00012	0.00126	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000118	0.00125	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000118	0.00125	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000115	0.00121	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000114	0.0012	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000113	0.0012	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—SDHA—dilated cardiomyopathy	0.000112	0.00118	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000112	0.00118	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000111	0.00117	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00011	0.00116	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00011	0.00116	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00011	0.00116	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00011	0.00116	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00011	0.00116	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000108	0.00114	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000108	0.00114	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000107	0.00112	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000107	0.00112	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000106	0.00111	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000105	0.00111	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000105	0.00111	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000104	0.0011	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000103	0.00109	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000102	0.00108	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000102	0.00107	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.0001	0.00106	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	9.91e-05	0.00104	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	9.88e-05	0.00104	CbGpPWpGaD
Dipivefrin—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	9.83e-05	0.00104	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	9.63e-05	0.00101	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—RAF1—dilated cardiomyopathy	9.45e-05	0.000996	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	9.45e-05	0.000996	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—ACE—dilated cardiomyopathy	9.36e-05	0.000987	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—ITGB1—dilated cardiomyopathy	9.14e-05	0.000963	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.11e-05	0.00096	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	9.06e-05	0.000955	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	8.83e-05	0.00093	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.78e-05	0.000925	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.78e-05	0.000925	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.64e-05	0.00091	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.55e-05	0.000901	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—ITGB1—dilated cardiomyopathy	8.54e-05	0.000899	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	8.46e-05	0.000892	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—RAF1—dilated cardiomyopathy	8.43e-05	0.000889	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.42e-05	0.000887	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.36e-05	0.000881	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	8.2e-05	0.000864	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	8.2e-05	0.000864	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	8.09e-05	0.000853	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	8.09e-05	0.000853	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.03e-05	0.000846	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	7.89e-05	0.000831	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	7.85e-05	0.000827	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.83e-05	0.000826	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	7.82e-05	0.000824	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—CD36—dilated cardiomyopathy	7.79e-05	0.000821	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	7.75e-05	0.000816	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.7e-05	0.000812	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	7.66e-05	0.000807	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	7.66e-05	0.000807	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.63e-05	0.000804	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	7.62e-05	0.000803	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	7.52e-05	0.000793	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	7.44e-05	0.000784	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	7.44e-05	0.000784	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	7.38e-05	0.000778	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	7.35e-05	0.000774	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	7.35e-05	0.000774	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	7.35e-05	0.000774	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	7.33e-05	0.000773	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	7.29e-05	0.000768	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	7.28e-05	0.000767	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	7.17e-05	0.000755	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	7.12e-05	0.00075	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.95e-05	0.000733	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.95e-05	0.000733	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	6.93e-05	0.000731	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.92e-05	0.000729	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.89e-05	0.000726	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.87e-05	0.000724	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	6.86e-05	0.000723	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.83e-05	0.00072	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	6.7e-05	0.000706	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.69e-05	0.000705	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.69e-05	0.000705	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—AGT—dilated cardiomyopathy	6.65e-05	0.000701	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	6.62e-05	0.000697	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.46e-05	0.000681	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	6.41e-05	0.000675	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.3e-05	0.000664	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	6.26e-05	0.00066	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.22e-05	0.000656	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.22e-05	0.000656	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.22e-05	0.000655	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.22e-05	0.000655	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.08e-05	0.00064	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.08e-05	0.00064	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.03e-05	0.000635	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.98e-05	0.00063	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	5.95e-05	0.000627	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—AGT—dilated cardiomyopathy	5.94e-05	0.000626	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	5.91e-05	0.000623	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.89e-05	0.00062	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.78e-05	0.000609	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.72e-05	0.000603	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.65e-05	0.000595	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.65e-05	0.000595	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.65e-05	0.000595	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.65e-05	0.000595	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.6e-05	0.00059	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.59e-05	0.000589	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	5.57e-05	0.000587	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.47e-05	0.000577	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.43e-05	0.000572	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	5.41e-05	0.00057	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.35e-05	0.000563	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.25e-05	0.000553	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.15e-05	0.000542	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.08e-05	0.000536	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.07e-05	0.000534	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.95e-05	0.000522	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.89e-05	0.000515	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.88e-05	0.000515	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	4.87e-05	0.000513	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.78e-05	0.000504	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.67e-05	0.000493	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.64e-05	0.000489	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.63e-05	0.000487	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.58e-05	0.000483	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	4.55e-05	0.000479	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.54e-05	0.000478	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.44e-05	0.000467	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.43e-05	0.000467	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.4e-05	0.000463	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.4e-05	0.000463	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.38e-05	0.000461	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.34e-05	0.000458	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.34e-05	0.000457	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.34e-05	0.000457	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.34e-05	0.000457	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.22e-05	0.000444	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.16e-05	0.000439	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.14e-05	0.000437	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.12e-05	0.000434	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.11e-05	0.000433	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.11e-05	0.000433	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.09e-05	0.000431	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.04e-05	0.000426	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.04e-05	0.000425	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	4.03e-05	0.000424	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	3.98e-05	0.000419	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.96e-05	0.000417	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.94e-05	0.000415	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—GPX1—dilated cardiomyopathy	3.91e-05	0.000412	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.91e-05	0.000412	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.82e-05	0.000402	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CD36—dilated cardiomyopathy	3.81e-05	0.000401	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.79e-05	0.000399	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	3.76e-05	0.000396	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.76e-05	0.000396	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.7e-05	0.00039	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	3.7e-05	0.000389	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.62e-05	0.000382	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.59e-05	0.000378	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.59e-05	0.000378	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.52e-05	0.000371	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—GPX1—dilated cardiomyopathy	3.49e-05	0.000368	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.44e-05	0.000363	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—AGT—dilated cardiomyopathy	3.43e-05	0.000361	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CD36—dilated cardiomyopathy	3.4e-05	0.000358	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.38e-05	0.000356	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.36e-05	0.000355	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.34e-05	0.000352	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.34e-05	0.000352	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.34e-05	0.000352	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.34e-05	0.000352	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.29e-05	0.000347	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.23e-05	0.000341	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.21e-05	0.000338	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.2e-05	0.000337	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.16e-05	0.000333	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.1e-05	0.000327	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—AGT—dilated cardiomyopathy	3.06e-05	0.000322	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.06e-05	0.000322	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	3.03e-05	0.000319	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3e-05	0.000317	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	3e-05	0.000316	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	2.95e-05	0.000311	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.8e-05	0.000295	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.76e-05	0.000291	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.76e-05	0.000291	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.76e-05	0.00029	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.72e-05	0.000287	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	2.66e-05	0.00028	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.62e-05	0.000276	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.61e-05	0.000275	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.57e-05	0.000271	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.57e-05	0.00027	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.49e-05	0.000262	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	2.46e-05	0.000259	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.46e-05	0.000259	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.43e-05	0.000256	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	2.4e-05	0.000253	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	2.38e-05	0.000251	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	2.35e-05	0.000248	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	2.33e-05	0.000245	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.28e-05	0.000241	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.25e-05	0.000237	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	2.22e-05	0.000234	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	2.16e-05	0.000227	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.12e-05	0.000223	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.09e-05	0.00022	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.03e-05	0.000214	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.94e-05	0.000205	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.92e-05	0.000202	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.89e-05	0.000199	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.89e-05	0.000199	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.81e-05	0.00019	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.79e-05	0.000189	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.65e-05	0.000174	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.63e-05	0.000172	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.57e-05	0.000165	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.54e-05	0.000163	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.45e-05	0.000153	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.35e-05	0.000142	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.25e-05	0.000132	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.13e-05	0.000119	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.12e-05	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.06e-05	0.000111	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	9.25e-06	9.74e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	8.59e-06	9.05e-05	CbGpPWpGaD
